Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Director at $KYMR Sells 4,900 Shares

Automated

Pamela Esposito, a director at $KYMR, sold 4,900 shares of the company on 01-20-2026 for an estimated $333,145. We received data on the trade from a recent SEC filing. This was a sale of approximately 96.1% of their shares of this class of stock. Following this trade, they now own 200 shares of this class of $KYMR stock.

$KYMR Insider Trading Activity

KYMR Insider Trades

$KYMR insiders have traded $KYMR stock on the open market 45 times in the past 6 months. Of those trades, 2 have been purchases and 43 have been sales.

Here’s a breakdown of recent trading of $KYMR stock by insiders over the last 6 months:

  • BROS. ADVISORS LP BAKER has made 2 purchases buying 2,005,813 shares for an estimated $172,499,918 and 0 sales.
  • BRUCE BOOTH has made 0 purchases and 14 sales selling 236,588 shares for an estimated $21,699,043.
  • NELLO MAINOLFI (Chief Executive Officer) has made 0 purchases and 7 sales selling 190,000 shares for an estimated $14,558,676.
  • JARED GOLLOB (Chief Medical Officer) has made 0 purchases and 11 sales selling 111,997 shares for an estimated $8,217,926.
  • BRUCE N. JACOBS (Chief Financial Officer) sold 79,220 shares for an estimated $3,961,380
  • PAMELA ESPOSITO has made 0 purchases and 7 sales selling 33,063 shares for an estimated $2,638,001.
  • JEFFREY W. ALBERS has made 0 purchases and 3 sales selling 10,000 shares for an estimated $744,772.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$KYMR Hedge Fund Activity

We have seen 125 institutional investors add shares of $KYMR stock to their portfolio, and 87 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$KYMR Analyst Ratings

Wall Street analysts have issued reports on $KYMR in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 01/15/2026
  • Stephens & Co. issued a "Overweight" rating on 12/11/2025
  • Mizuho issued a "Outperform" rating on 12/11/2025
  • JP Morgan issued a "Overweight" rating on 12/10/2025
  • Jefferies issued a "Buy" rating on 12/09/2025
  • Citigroup issued a "Buy" rating on 12/09/2025
  • Leerink Partners issued a "Outperform" rating on 12/09/2025

To track analyst ratings and price targets for $KYMR, check out Quiver Quantitative's $KYMR forecast page.

$KYMR Price Targets

Multiple analysts have issued price targets for $KYMR recently. We have seen 18 analysts offer price targets for $KYMR in the last 6 months, with a median target of $118.5.

Here are some recent targets:

  • Jeet Mukherjee from BTIG set a target price of $138.0 on 01/15/2026
  • Kalpit Patel from B. Riley Securities set a target price of $117.0 on 12/22/2025
  • Brian Abrahams from RBC Capital set a target price of $103.0 on 12/16/2025
  • Joseph Catanzaro from Mizuho set a target price of $120.0 on 12/11/2025
  • Sudan Loganathan from Stephens & Co. set a target price of $110.0 on 12/11/2025
  • Brian Cheng from JP Morgan set a target price of $125.0 on 12/10/2025
  • Tazeen Ahmad from B of A Securities set a target price of $112.0 on 12/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles